GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » PEG Ratio

Shandong Sito Bio-technology Co (SZSE:300583) PEG Ratio : N/A (As of Mar. 28, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Shandong Sito Bio-technology Co's PE Ratio without NRI is 295.29. Shandong Sito Bio-technology Co's 5-Year EBITDA growth rate is 0.00%. Therefore, Shandong Sito Bio-technology Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Shandong Sito Bio-technology Co's PEG Ratio or its related term are showing as below:



SZSE:300583's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.42
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Shandong Sito Bio-technology Co PEG Ratio Historical Data

The historical data trend for Shandong Sito Bio-technology Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co PEG Ratio Chart

Shandong Sito Bio-technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shandong Sito Bio-technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shandong Sito Bio-technology Co's PEG Ratio

For the Biotechnology subindustry, Shandong Sito Bio-technology Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Sito Bio-technology Co's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Sito Bio-technology Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Sito Bio-technology Co's PEG Ratio falls into.


;
;

Shandong Sito Bio-technology Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Shandong Sito Bio-technology Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=295.29411764706/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Shandong Sito Bio-technology Co  (SZSE:300583) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Shandong Sito Bio-technology Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Shandong Sito Bio-technology Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sito Bio-technology Co Business Description

Traded in Other Exchanges
N/A
Address
South Section of East Outer Ring Road, Dingtao District, Shandong Province, Heze, CHN, 274100
Shandong Sito Bio-technology Co Ltd is a biotechnology company. It uses genetic engineering technology and microbial transformation technology to develop and produce steroid drug raw materials, specialty respiratory raw materials and finished preparations, and other drug intermediaries. The company operates in the following business segments; intermediates, high-end specialty respiratory APIs, and preparations. Its product offerings include androstenedione (AD), 9-hydroxy androstenedione (90H-AD), 17a-hydroxyprogesterone derivatives (A ring), and bi-decanoic acid (BA), and others. In addition, the company holds patents for various APIs and other intermediaries.
Executives
Mi Qi Directors, executives
Wang Min Director
Kong Qing Zhi Executives
He Jian Yong Directors, executives
Ceng Qing Li Securities Affairs Representative

Shandong Sito Bio-technology Co Headlines

No Headlines